Voluntary announcement entering into strategic cooperation with xtalpi
Filed with HKEX · Stock code 3378 · · 3 pages · English
翰思艾泰 Hanx Biopharmaceuticals (Wuhan) Co., Ltd. 翰思艾泰生物醫藥科技（武漢）股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 3378) VOLUNTARY ANNOUNCEMENT ENTERING INTO STRATEGIC COOPERATION WITH XTALPI This announcement is made by the board (the “Board”) of directors (the “Directors”) of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (the “Company” or“
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. on 6ix
Earlier from Hanx Biopharmaceuticals (Wuhan)
- 2026 Interim report
- Proposed placing of unlisted warrants under Specific mandate
- Next Day Disclosure Return
- Voluntary announcement notice on voluntary extension of lock-up period by shareholders
- Voluntary announcement inclusion of Hanx Biopharmaceuticals in the FTSE global micro cap index
Later from Hanx Biopharmaceuticals (Wuhan)
All Hanx Biopharmaceuticals (Wuhan) news releasesFollow Hanx Biopharmaceuticals (Wuhan) into a list and get an email when it puts out news.
Follow Hanx Biopharmaceuticals (Wuhan)